VerbatimParliament, as it happens

Tirzepatide

Asked by Lee AndersonReform UKDepartment of Health and Social CareTabled Answered 30 October 2024UIN 10140

The question

To ask the Secretary of State for Health and Social Care, with reference to his Department's press release entitled Landmark collaboration with largest pharmaceutical company, published on 14 October 2024, how many times will a patient be allowed to take a course of Mounjaro, in the context of the five year trial in Greater Manchester.

Answered by Andrew Gwynne

As announced on 14 October 2024, the SURMOUNT-REAL clinical trial of tirzepatide, brand name Mounjaro, is being developed between Health Innovation Manchester, The University of Manchester, and Eli Lilly and Company, with further details about the study to be published at a later date by these organisations, following on from relevant approvals.

Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →

Open this question in Verbatim →

Every written question, searchable

155,000 questions tabled since the election, with the answer each department gave — and the ones still unanswered, with the clock running. Free to search.

Search written questions →Read on Verbatim